Evidence map›Paper›PMID 32769157›Full record

ArticleAnnals of the rheumatic diseases2021

Impact of the COVID-19 lockdown on the management and control of patients with GCA.

Roman Praliaud, Helene Greigert, Maxime Samson, Marianne Zeller, Mathieu Boulin, Philip Bielefeld, André Ramon, Yves Cottin, Bernard Bonnotte

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Annals of the rheumatic diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. COVID-19 Lockdown in Patients with Chronic Diseases: A Cross-Sectional Study.International journal of environmental research and public health · 2022
    Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Roman Praliaud *Department of Internal Medicine and Clinical Immunology, University Hospital Centre Dijon, Dijon, France.
Helene Greigert *Department of Internal Medicine and Clinical Immunology, University Hospital Centre Dijon, Dijon, France.
Maxime SamsonDepartment of Internal Medicine and Clinical Immunology, University Hospital Centre Dijon, Dijon, France.ORCID 0000-0002-6547-232X
Marianne ZellerDepartment of Cardiology, University Hospital Centre Dijon, Dijon, France.
Mathieu BoulinDepartment of Pharmacy, University Hospital Centre Dijon, Dijon, France.
Philip BielefeldDepartment of Internal Medicine and Clinical Immunology, University Hospital Centre Dijon, Dijon, France.
André RamonDepartment of Rheumatology, University Hospital Centre Dijon, Dijon, France.
Yves CottinDepartment of Cardiology, University Hospital Centre Dijon, Dijon, France.
Bernard BonnotteDepartment of Internal Medicine and Clinical Immunology, University Hospital Centre Dijon, Dijon, France bernard.bonnotte@chu-dijon.fr.ORCID 0000-0001-7229-3808

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Giant Cell ArteritisPolymyalgia RheumaticaCommunicable Disease ControlHumansgiant cell arteritisoutcome and process assessment, health carepolymyalgia rheumatica

Identifiers

PMID32769157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.